Sleep News and Research

Latest Sleep News and Research

'Hormone of darkness' melatonin regulates sleep effectively

Melatonin, a natural hormone segregated by the own human body, is an excellent sleep regulator expected to replace somniferous, which are much more aggressive, to correct the sleep/wakefulness pace when human biological clock becomes altered.

6 Nov 2009

New breast reconstruction surgery for women

Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too.

6 Nov 2009

USPTO issues Notice of Allowance to NovaDel Pharma

NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.

6 Nov 2009

Prescription drug abuse among teens: NCPIE, SAMHSA launches campaign

The National Council on Patient Information and Education (NCPIE), along with the Substance Abuse and Mental Health Services Administration (SAMHSA) and representatives from 15 nationally recognized prevention, health professional and child advocacy organizations, are launching Maximizing Your Role as a Teen Influencer: What You Can Do to Help Prevent Teen Prescription Drug Abuse.

6 Nov 2009

First-quarter fiscal 2010 results announced by Continucare

Continucare Corporation today reported financial results for its first quarter of fiscal 2010.

5 Nov 2009

Asthma in 9/11 responders is two times greater than general US population

Responders to the 2001 World Trade Center (WTC) terrorist attacks, who were exposed to caustic dust and toxic pollutants following the 9/11 disaster, suffer from asthma at a rate more than twice that of the general US population, according to new research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).

5 Nov 2009

CHANTIX/CHAMPIX raises hope for quitting smoking

New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p<0.0001). These findings were presented by investigators at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).

5 Nov 2009

Surgery may not be the best option for children with obstructive sleep apnea

For children with obstructive sleep apnea, standard care often includes a tonsillectomy and adenoidectomy. But researchers at Saint Louis University say further research is needed to determine if surgery is the best option for these patients.

5 Nov 2009

Statins may have negative effects on some cardiac patients, says study

Although statins are widely used to prevent heart attacks, strokes, and other cardiovascular disorders, new research shows that the class of drugs may actually have negative effects on some cardiac patients. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that statins have beneficial effects on patients with systolic heart failure (SHF), but those with diastolic heart failure (DHF) experienced the opposite effect, including increased dyspnea, fatigue, and decreased exercise tolerance.

4 Nov 2009

USPTO issues Notice of Allowance for Transcept Pharmaceuticals' Intermezzo

Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/833,323, which covers the use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate. Once issued, this patent will expire in February 2025.

4 Nov 2009

iPhone application for analyzing sleep apnea developed

Remote Analysis Ltd, a telemedicine services provider, has in cooperation with Elias Pietilä’s Qvik Ltd (Wooden Labyrinth, for example) developed an iPhone application for recording and analyzing snoring and sleep apnea. The Sleep Aid –application is now available on the iPhone App Store for € 2,39.

4 Nov 2009

Tinnitus patients need more support and advice on healthcare options

As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.

4 Nov 2009

Hispanics are more likely to report increase in stress levels than whites or blacks: APA survey

Stress has a greater impact on young people than parents believe and Hispanics are more likely than whites or blacks to report an increase in stress levels over the last year, according to a new national survey released today by the American Psychological Association (APA).

4 Nov 2009

ASTI's 'Tell-a-Friend program' for solving sleep-related problems

Adaptive Sound Technologies, Inc. (ASTI) announced today that it will pay cash rewards to ASTI customers who refer friends that in turn buy an Ecotones or Ecotones Duet directly from ASTI. The new "Tell-a-Friend" program rewards customers for doing what they have been doing since the first Ecotones was introduced late last year: letting friends in on the secret to better sleep.

4 Nov 2009

Stress related to school pressure and family finances has greater impact on young people

Stress related to school pressure and family finances has a greater impact on young people than parents believe, according to a new national survey released today by the American Psychological Association (APA).

4 Nov 2009

Coffee affects quality of daytime recovery sleep

Night-shift workers should avoid drinking coffee if they wish to improve their sleep, according to research published in the journal Sleep Medicine. A new study led by Julie Carrier, a Universit- de Montr-al psychology professor and a researcher at the affiliated H-pital du Sacr--C-ur Sleep Disorders Centre, has found the main byproduct of coffee, caffeine, interferes with sleep and this side-effect worsens as people age.

4 Nov 2009

NIH awards $4 million research grant to AllTranz

AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company’s transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.

3 Nov 2009

Caucasian women may suffer from RLS up to four times more than African-American women

New research shows that Caucasian women may suffer from restless legs syndrome (RLS), a sleep disorder characterized by the strong urge to move the legs, up to four times more than African-American women. The study, presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that, overall, non-African-American (NAA) patients experienced RLS four times more often than African-Americans (AA).

3 Nov 2009

Nasal positive airway pressure therapy for sleep apnea golfers may improve their game

Golfers who undergo treatment for sleep apnea may improve their golf game as well as their overall health, shows new research. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that golfers with obstructive sleep apnea (OSA) who received nasal positive airway pressure (NPAP) for their disorder improved their daytime sleepiness scores and lowered their golf handicap by as much as three strokes.

3 Nov 2009

Raycop's anti-bacterial vacuum cleaning system with UVC technology kills the H1N1 virus

Raycop, the first handheld anti-bacterial vacuum cleaning system and part of the Earlex® brands, offers a proven way to fight the H1N1 virus in the home with its UVC technology. The vac's effects against the virus have been independently tested by a leading international laboratory in August.

3 Nov 2009